2014 was a big year for acquisitions, and two in particular suggest that 2015 will be a big year for antibiotics. In October, Actavis acquired Durata, […]
Chief Operating Officer Giovanni Caforio will take over as CEO of Bristol-Myers Squibb on May 5. Lamberto Andreotti, CEO of 5 years, will step down and […]
The life sciences industry is entering an “Era of Interdependence.” Different sectors of the industry are realizing that cooperation is the key success. In the […]
On January 12, the FDA launched its Office of Pharmaceutical Quality, in order to establish consistent quality standards for all drugs and to cut quality control […]
Biotech visionary G. Steven Burrill, CEO of Burrill LLC and Burrill Media, issues annual predictions for the life sciences at the start of each year. […]
The Greater Reading Medical Device Group, created in 2001, is made up of over 80 Greater Reading Professionals. Started by the Ben Franklin Technology Partners of […]